SOPHiA GENETICS

Find the latest for SOPHiA GENETICS company news

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

I started a nonprofit to fight ALS after my husband's death. Here's how tech and AI can help us find a cure.

After her husband passed away from ALS, Indu Navar started an organization that uses AI to study ALS and other neurological diseases.

Secure AI Collaboration Will Fine-Tune OpenFold3 with Proprietary Data

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

Aiforia Technologies Oyj: Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology

Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology Aiforia Technologies Plc, Press Release, March 21, 2025 at 09:00 a.m. EET Aiforia, a trusted provider of d

Princeton Precision Health: An interdisciplinary, AI-driven approach to tackling big questions about health and disease

PPH researchers apply cutting-edge AI and computational models to massive datasets to develop a deep understanding of the factors that shape health and illness.

Deep learning uncovers gene targets and potential drugs to slow brain aging

In a new study reported in Science Advances, scientists analyzed MRI data stored at the UK Biobank and identified seven genes responsible for fast biological brain aging and 13 existing drugs that can target those genes.

Deep Learning 7month
The role of data revolution in rare disease research

The arrival of big data, artificial intelligence (AI), and shared databases, offers unparallelled potential for advancing the study and treatment of rare diseases

UNC Charlotte research advances the transformation of gene therapy, life sciences with emerging tech and AI

UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease forecasting and prevention, optical applications for health care, and use of AI and other innovative computational tools — and more.